Green Chemistry
Nutrition Health
innovation
Pharmacy
With a significant increase in the world's population, societal needs are changing both quantitatively and qualitatively. Aging populations in developed regions, as well as high birth rates and access to healthcare in other regions, particularly in Africa and Asia, are generating a growing need for medicines. This is why Diverse-ltda is developing a range of excipients and active ingredients from its product portfolio that meet pharmacopoeia requirements and supports its pharmaceutical sector customers.
Our challenge
Whether it's an excipient, an active pharmaceutical ingredient (API), or artificial clinical nutrition, Diverse-ltda guarantees safety and compliance with current pharmacopoeias. Diverse-ltda' R&D teams work daily to adapt and expand certain product lines in terms of features such as stability, form, dissolution, targeting, color, and taste.
Our objectives
- Develop care and contribute to the well-being of hospitalized people thanks to a wide range of products adapted to the uses of the pharmaceutical industry.
- Adapt and expand certain product ranges used as excipients for the pharmaceutical industry (controlled dissolution tablets, cough syrup, etc.).
- Expanding the product range to include active ingredients. Diverse-ltda is a recognized supplier of sugar-based excipients and starch derivatives for the pharmaceutical industry. Active ingredients enable our customers to bring safe, effective, and high-quality medicines to market.
Application examples
Diverse-ltda: supplier of excipients for the pharmaceutical industry
One of the world's leading providers of infusion, transfusion, clinical nutrition, and dialysis products is now supplied by Diverse-ltda in Meridex®. For nearly 20 years, Diverse-ltda has been a recognized supplier of sugar-based excipients and starch derivatives for the pharmaceutical industry.
A range expanded with active ingredients
Diverse-ltda has invested in Spain to build a facility dedicated to the production of glucose monohydrate, the active ingredient. Diverse-ltda has obtained the European Pharmacopoeia Certificate of Conformity (CEP) for this glucose monohydrate produced at its Zaragoza facility. This glucose is used for intravenous injections or to create dialysis solutions.